These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15957961)

  • 1. Proton pump inhibitors may reduce tumour resistance.
    De Milito A; Fais S
    Expert Opin Pharmacother; 2005 Jun; 6(7):1049-54. PubMed ID: 15957961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.
    Luciani F; Spada M; De Milito A; Molinari A; Rivoltini L; Montinaro A; Marra M; Lugini L; Logozzi M; Lozupone F; Federici C; Iessi E; Parmiani G; Arancia G; Belardelli F; Fais S
    J Natl Cancer Inst; 2004 Nov; 96(22):1702-13. PubMed ID: 15547183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor acidity, chemoresistance and proton pump inhibitors.
    De Milito A; Fais S
    Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells.
    Chen M; Zou X; Luo H; Cao J; Zhang X; Zhang B; Liu W
    Cell Biol Int; 2009 Sep; 33(9):1008-19. PubMed ID: 19501661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma.
    Lee YY; Jeon HK; Hong JE; Cho YJ; Ryu JY; Choi JJ; Lee SH; Yoon G; Kim WY; Do IG; Kim MK; Kim TJ; Choi CH; Lee JW; Bae DS; Kim BG
    Oncotarget; 2015 Oct; 6(33):35040-50. PubMed ID: 26418900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.
    Chen M; Huang SL; Zhang XQ; Zhang B; Zhu H; Yang VW; Zou XP
    J Cell Biochem; 2012 Jul; 113(7):2474-87. PubMed ID: 22396185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myrtenal-induced V-ATPase inhibition - A toxicity mechanism behind tumor cell death and suppressed migration and invasion in melanoma.
    Martins BX; Arruda RF; Costa GA; Jerdy H; de Souza SB; Santos JM; de Freitas WR; Kanashiro MM; de Carvalho ECQ; Sant'Anna NF; Antunes F; Martinez-Zaguilan R; Souad S; Okorokova-Façanha AL; Façanha AR
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):1-12. PubMed ID: 30279148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer.
    He J; Shi XY; Li ZM; Pan XH; Li ZL; Chen Y; Yan SJ; Xiao L
    BMC Mol Cell Biol; 2019 Nov; 20(1):49. PubMed ID: 31718559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH and drug resistance. II. Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs.
    Raghunand N; Martínez-Zaguilán R; Wright SH; Gillies RJ
    Biochem Pharmacol; 1999 May; 57(9):1047-58. PubMed ID: 10796075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V-ATPase as an effective therapeutic target for sarcomas.
    Perut F; Avnet S; Fotia C; Baglìo SR; Salerno M; Hosogi S; Kusuzaki K; Baldini N
    Exp Cell Res; 2014 Jan; 320(1):21-32. PubMed ID: 24416789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H⁺)-ATPase Inhibitors.
    Patil R; Kulshrestha A; Tikoo A; Fleetwood S; Katara G; Kolli B; Seibel W; Gilman-Sachs A; Patil SA; Beaman KD
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28926955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump.
    Fan S; Niu Y; Tan N; Wu Z; Wang Y; You H; Ke R; Song J; Shen Q; Wang W; Yao G; Shu H; Lin H; Yao M; Zhang Z; Gu J; Qin W
    Oncogene; 2013 Mar; 32(13):1682-90. PubMed ID: 22580606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer.
    Lindner K; Borchardt C; Schöpp M; Bürgers A; Stock C; Hussey DJ; Haier J; Hummel R
    J Exp Clin Cancer Res; 2014 Sep; 33(1):73. PubMed ID: 25175076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells.
    You H; Jin J; Shu H; Yu B; De Milito A; Lozupone F; Deng Y; Tang N; Yao G; Fais S; Gu J; Qin W
    Cancer Lett; 2009 Jul; 280(1):110-9. PubMed ID: 19299075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer.
    Hernandez A; Serrano-Bueno G; Perez-Castineira JR; Serrano A
    Curr Pharm Des; 2012; 18(10):1383-94. PubMed ID: 22360554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo.
    Lu ZN; Shi ZY; Dang YF; Cheng YN; Guan YH; Hao ZJ; Tian B; He HW; Guo XL
    Biomed Pharmacother; 2019 Dec; 120():109478. PubMed ID: 31568987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.
    De Milito A; Iessi E; Logozzi M; Lozupone F; Spada M; Marino ML; Federici C; Perdicchio M; Matarrese P; Lugini L; Nilsson A; Fais S
    Cancer Res; 2007 Jun; 67(11):5408-17. PubMed ID: 17545622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer.
    Song T; Jeon HK; Hong JE; Choi JJ; Kim TJ; Choi CH; Bae DS; Kim BG; Lee JW
    Cancer Res Treat; 2017 Jul; 49(3):595-606. PubMed ID: 27669706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines.
    Martínez-Zaguilán R; Raghunand N; Lynch RM; Bellamy W; Martinez GM; Rojas B; Smith D; Dalton WS; Gillies RJ
    Biochem Pharmacol; 1999 May; 57(9):1037-46. PubMed ID: 10796074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism.
    Fais S
    J Intern Med; 2010 May; 267(5):515-25. PubMed ID: 20433578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.